NOVT
TechnologyNovanta Inc. · Hardware, Equipment & Parts · $6B
What is Novanta Inc.?
Novanta Inc. is a technology company supplying precision components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. Its products span photonics, vision, and precision motion technologies.
Novanta generates revenue by designing, manufacturing, and selling engineered components to OEMs that embed them into medical devices and industrial equipment. Its three segments — Photonics, Vision, and Precision Motion — each address distinct application areas. Customers rely on Novanta's sub-systems for laser processing, surgical visualization, robotic automation, and related precision tasks rather than purchasing finished end products directly.
Founded in 1999 and headquartered in Bedford, US, Novanta has built a portfolio of specialized technology brands serving demanding end markets.
- Laser scanning, beam delivery, and CO2 laser products
- Medical visualization, insufflators, and operating room integration technologies
- Optical encoders, precision motors, and servo drive solutions
- Robotic end-of-arm technology and air bearing spindles
Is NOVT a Good Stock to Buy?
UQS Score rates NOVT as Below Average overall.
The Risk pillar stands out as the clearest positive in Novanta's profile, suggesting the business carries a relatively manageable risk profile compared to many peers in the technology sector.
The Quality, Moat, and Growth pillars all register as Weak, pointing to meaningful challenges in competitive positioning, earnings quality, and near-term expansion. Valuation is rated Elevated, which adds further caution for prospective investors.
See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does NOVT pay dividends?
No — Novanta Inc. does not currently pay a dividend.
Novanta does not currently pay a dividend. As a technology-oriented manufacturer focused on specialized OEM components, the company directs available capital toward product development, acquisitions, and operational investment rather than distributing cash to shareholders. Income-focused investors should factor this into their assessment.
When does NOVT report earnings?
Novanta reports earnings on a quarterly cadence, consistent with standard practice for US-listed equities.
The company's recent results reflect the challenges captured in its Weak Growth and Quality pillar ratings. Revenue trends and profitability metrics have faced headwinds across its end markets, particularly in industrial applications.
For the most recent quarter's results and guidance, visit Novanta's investor relations page directly.
NOVT Price History
-4.7% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Novanta Inc.?
Based on Novanta Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
NOVT Long-term Outlook
Novanta's fundamental outlook is shaped by Weak Growth and Weak Quality pillar ratings, suggesting near-term expansion is unlikely to be a primary driver of returns. The Strong Risk rating provides some stability, but the Elevated Valuation label indicates the market may already be pricing in a more optimistic scenario than the underlying fundamentals currently support.
Growth drivers
- Exposure to long-cycle medical device OEM demand, which tends to be more resilient than pure industrial markets
- Potential for precision motion and robotics applications to benefit from broader automation trends
- Acquisition-driven portfolio expansion across its three technology segments
Key risks
- Weak Moat rating suggests limited pricing power and vulnerability to competitive displacement
- Elevated Valuation leaves little margin of safety if growth disappoints
- Industrial market softness could weigh on Photonics and Precision Motion segment revenues
NOVT vs Peers
Novanta operates in a specialized niche of precision technology components, where it competes with a range of engineering-focused companies across photonics, sensing, and industrial systems.
MDA focuses on space technology and robotics for satellite and space exploration applications, targeting a more government-driven customer base than Novanta's OEM-centric model.
Itron specializes in smart metering and resource management technology for utilities, competing in sensing and data collection but serving a distinct end market from Novanta's medical and industrial OEM focus.
OSI Systems provides security inspection and optoelectronics products, overlapping with Novanta in photonics and sensing technologies while serving security and healthcare end markets.
Frequently Asked Questions
What does Novanta do?
Novanta designs and manufactures precision photonics, vision, and motion components sold to OEMs in the medical and industrial sectors. Its products are embedded into equipment used for laser processing, surgical visualization, robotic automation, and precision measurement rather than sold directly to end users.
Does NOVT pay dividends?
No, Novanta does not pay a dividend. The company reinvests available capital into product development and acquisitions rather than distributing cash to shareholders. Investors seeking regular income should consider this when evaluating NOVT.
When does NOVT report earnings?
Novanta reports financial results on a quarterly basis, in line with standard US-listed company practice. For the exact schedule and most recent results, check Novanta's official investor relations page.
Is NOVT a good stock to buy?
UQS Score rates NOVT as Below Average, reflecting Weak ratings across Quality, Moat, and Growth pillars alongside an Elevated Valuation. The Risk pillar is Strong, which is a relative positive. The complete pillar breakdown is available to UQS Pro members.
Is NOVT overvalued?
The UQS Valuation pillar for NOVT is rated Elevated, suggesting the current market price may not offer a wide margin of safety relative to the company's underlying fundamentals. Investors should weigh this against the Weak Growth profile.
How does NOVT compare to its competitors?
Novanta occupies a specialized niche in precision OEM components for medical and industrial markets. Compared to peers like OSI Systems and Itron, Novanta's differentiation lies in its multi-segment photonics and motion technology portfolio, though its Weak Moat rating suggests competitive advantages are not strongly entrenched.
What is NOVT's market cap bracket?
Novanta is classified as a mid-cap company. This places it in a segment of the market that can offer growth potential beyond large-caps while carrying more stability than small- or micro-cap peers, though individual fundamentals vary significantly.
Who founded Novanta?
Novanta was founded in 1999. Detailed founding history, including key individuals involved, is publicly available through the company's official communications and financial filings.
Is NOVT a long-term quality stock?
As a long-term quality indicator, NOVT's Below Average UQS Score — driven by Weak Quality, Moat, and Growth ratings — raises questions about durable competitive advantage. The Strong Risk pillar is a constructive signal, but sustained long-term quality typically requires stronger scores across multiple pillars.
What is the main competitive advantage of Novanta?
Novanta's positioning in highly engineered, application-specific components for medical OEMs provides some degree of customer stickiness. However, the UQS Moat pillar is rated Weak, indicating that these advantages may not be as durable or wide as those seen in higher-rated peers within the technology sector.
Unlock Full NOVT Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the exact UQS Score and all five pillar ratings for NOVT
- ✓Access detailed financial metrics and trend data
- ✓Compare NOVT side-by-side with sector peers on quality and valuation
- ✓Screen for stronger-rated mid-cap technology alternatives
- ✓Get the complete analyst-style breakdown available to Pro members
Pro Analysis
NOVT — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | 36.9 | 21.8 | 27.0 | 29.3 | 87.9 | 37.8 | -0.1 |
| May 3, 2026 | 37.0 | 21.8 | 27.0 | 29.3 | 87.9 | 38.6 | 0.0 |
| Apr 26, 2026 | 37.0 | 21.8 | 27.0 | 29.3 | 87.9 | 38.2 | -0.1 |
| Apr 19, 2026 | 37.1 | 21.8 | 27.0 | 29.3 | 87.9 | 39.0 | 0.0 |
| Apr 18, 2026 | 37.1 | 21.8 | 27.0 | 29.3 | 87.9 | 38.9 | -0.6 |
| Apr 14, 2026 | 37.7 | 21.8 | 27.0 | 29.3 | 87.9 | 43.1 | 0.0 |
| Apr 12, 2026 | 37.7 | 21.8 | 27.0 | 29.3 | 87.9 | 43.4 | -0.2 |
| Apr 5, 2026 | 37.9 | 21.9 | 27.0 | 29.3 | 87.9 | 44.3 | 0.0 |
| Apr 2, 2026 | 37.9 | 21.9 | 27.0 | 29.3 | 87.9 | 44.1 | — |
NOVT — Pillar Breakdown
Quality
— 21.1/100 (25%)Novanta Inc. currently shows below-average quality metrics, suggesting challenges with profitability.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 29.9/100 (20%)Novanta Inc. faces growth headwinds with declining or stagnant revenue trends.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 89.4/100 (15%)Novanta Inc. carries minimal financial risk with conservative leverage and strong solvency.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 35.4/100 (15%)Novanta Inc. has a mixed valuation — some metrics suggest fair value while others appear stretched.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 27/100 (25%)Novanta Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for NOVT.
Score Composition
Financial Data
More Stock Analysis
How is the NOVT UQS Score Calculated?
The UQS (Unified Quality Score) for Novanta Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Novanta Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Novanta Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.